“Strategy Inc. assisted our company with the development of an Investor Presentation and a Valuation Top Line clarifying the value proposition of our novel technologies. Strategy Inc. also performed due diligence to support closing our first round 6 Million Euros investment from Ysios Capital Partners, La Caixa and ICO Axis – an exciting time for our company. We sincerely appreciated the efforts and deliverables of Strategy Inc. and are pleased to be able to move to the next stage of our development.” ✦ Victor Garcia Llorente. Operations Director and Vincent Ribas Ripoll R&D Director
SabirMedical, is an applied research company located in the Bio-Incubator Science Park in Barcelona Spain focused in the development of novel technologies for diagnosis, home and patient care. SabirMedical’s initial technology is a game changing non-invasive cardiac monitoring technology.